Activation of the Amyloid Cascade in Apolipoprotein E4 Transgenic Mice Induces Lysosomal Activation and Neurodegeneration Resulting in Marked Cognitive Deficits
暂无分享,去创建一个
[1] Kim N. Green,et al. Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.
[2] D. Holtzman,et al. Apolipoprotein E and Low Density Lipoprotein Receptor-related Protein Facilitate Intraneuronal Aβ42 Accumulation in Amyloid Model Mice* , 2006, Journal of Biological Chemistry.
[3] M. Goedert,et al. A Century of Alzheimer's Disease , 2006, Science.
[4] Colin L Masters,et al. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. , 2006, Brain : a journal of neurology.
[5] Jialing Liu,et al. Enriched environment and spatial learning enhance hippocampal neurogenesis and salvages ischemic penumbra after focal cerebral ischemia , 2006, Neurobiology of Disease.
[6] M. Gallagher,et al. A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.
[7] R. Mahley,et al. Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. , 2006, The Journal of biological chemistry.
[8] D. Holtzman,et al. Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model , 2005, The Journal of Neuroscience.
[9] F. LaFerla,et al. Amyloid β-Peptide: The Inside Story , 2004 .
[10] T. Bayer,et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. , 2004, The American journal of pathology.
[11] D. Michaelson,et al. A nontransgenic mouse model shows inducible amyloid-β (Aβ) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade , 2004 .
[12] A. Roses,et al. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory , 2003, Neurobiology of Disease.
[13] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[14] K. Beyreuther,et al. γ-Secretase Cleavage Site Specificity Differs for Intracellular and Secretory Amyloid β* , 2003, The Journal of Biological Chemistry.
[15] D. Holtzman,et al. Apolipoprotein E4 Influences Amyloid Deposition But Not Cell Loss after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[16] P. Greengard,et al. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. , 2002, The American journal of pathology.
[17] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[18] R. Mahley,et al. Apolipoprotein E4 Potentiates Amyloid β Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal Cells* , 2002, The Journal of Biological Chemistry.
[19] D. Westaway,et al. Aβ-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Aβ pathology , 2002, Neuroscience Research.
[20] A. Fagan,et al. Human and Murine ApoE Markedly Alters Aβ Metabolism before and after Plaque Formation in a Mouse Model of Alzheimer's Disease , 2002, Neurobiology of Disease.
[21] D. Holtzman,et al. Role of apoE/Aβ interactions in Alzheimer's disease: insights from transgenic mouse models , 2002, Molecular Psychiatry.
[22] Hiroaki Kazui,et al. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele , 2002 .
[23] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[24] Guiquan Chen,et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease , 2000, Nature.
[25] A. Fagan,et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Gilbert,et al. Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.
[27] R J Miller,et al. Isoform-Specific Effect of Apolipoprotein E on Cell Survival and β-Amyloid-Induced Toxicity in Rat Hippocampal Pyramidal Neuronal Cultures , 1998, The Journal of Neuroscience.
[28] U. Frey,et al. Hippocampal synaptic plasticity: role in spatial learning or the automatic recording of attended experience? , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[29] R. Nixon,et al. Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.
[30] N. Maeda,et al. Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.
[31] G. Getz,et al. Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal Cultures , 1997, Journal of neurochemistry.
[32] Thomas Arendt,et al. Plastic Neuronal Remodeling Is Impaired in Patients with Alzheimer’s Disease Carrying Apolipoprotein ε4 Allele , 1997, The Journal of Neuroscience.
[33] G. Getz,et al. Isoform-specific binding of apolipoprotein E to beta-amyloid. , 1994, The Journal of biological chemistry.
[34] J. Troncoso,et al. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease , 1994, The Lancet.
[35] A D Roses,et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[38] P. Luiten,et al. Changes in PKC gamma immunoreactivity in mouse hippocampus induced by spatial discrimination learning , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[39] Xu Jing-ying,et al. On the English Translation of , 2010 .
[40] R. Demattos,et al. Apolipoprotein E dose-dependent modulation of β-amyloid deposition in a transgenic mouse model of Alzheimer’s disease , 2007, Journal of Molecular Neuroscience.
[41] F. LaFerla,et al. Intracellular amyloid-beta in Alzheimer's disease. , 2007, Nature reviews. Neuroscience.
[42] D. Holtzman. In vivo effects of apoE and clusterin on amyloid-β metabolism and neuropathology , 2007, Journal of Molecular Neuroscience.
[43] Michela Gallagher,et al. A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.
[44] D. Michaelson,et al. The nucleation growth and reversibility of Amyloid-beta deposition in vivo. , 2006, Journal of Alzheimer's disease : JAD.
[45] R. Nixon,et al. Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[46] A. Roses. On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. , 2006, Journal of Alzheimer's disease : JAD.
[47] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. , 2006, Journal of Alzheimer's disease : JAD.
[48] D. Michaelson,et al. The nucleation growth and reversibility of Amyloid-β deposition in vivo , 2006 .
[49] D. Michaelson,et al. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[50] Frank M LaFerla,et al. Amyloid beta-peptide: the inside story. , 2004, Current Alzheimer research.
[51] D. Holtzman. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. , 2004, Journal of molecular neuroscience : MN.
[52] K. Beyreuther,et al. gamma-Secretase cleavage site specificity differs for intracellular and secretory amyloid beta. , 2003, The Journal of biological chemistry.
[53] Hiroaki Kazui,et al. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. , 2002, Annals of neurology.
[54] D. Holtzman,et al. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models. , 2002, Molecular psychiatry.
[55] P. S. St George-Hyslop,et al. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. , 2002, Neuroscience research.
[56] R. Stelzmann,et al. An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde” , 1995, Clinical anatomy.
[57] M A Pericak-Vance,et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.
[58] E. Giacobini. The cholinergic system in Alzheimer disease. , 1990, Progress in brain research.